Therapeutic Area Solutions

eCOA experience across therapeutic areas

From complex oncology protocols to high-volume vaccine studies, Medable brings clinical expertise, patient-centered technology, and global delivery experience to eCOA, eConsent, and more.

Person with a shaved head wearing an orange sweater, reclining on a couch using a tablet.

Clinical Depth Across Therapeutic Areas

Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here.

Oncology
Support complex oncology protocols, diverse indications, patient-reported outcomes, and global study execution with flexible eCOA solutions.
Vaccines
Enable rapid enrollment, time-sensitive reactogenicity reporting, and consistent patient adherence in high-volume studies.
Cardiometabolic & Weight Loss
Support longitudinal assessments and recurring patient reporting while maintaining engagement and consistent data collection over time.
Rare Disease
Address specialized assessment needs and caregiver participation across complex patient populations.
Women's Health
Support sensitive assessments and symptom reporting with patient-centered approaches that help reduce participation burden.
Pediactric
Support age-appropriate assessments and caregiver-reported outcomes with eCOA experiences designed for young patients and their families.

From protocol complexity to portfolio efficiency

Accelerate study startup

Medable Study Studio helps teams streamline eCOA design and implementation with reusable components, established instrument knowledge, and more efficient study builds.

Support patient and site adherence

Intuitive user experiences help make reporting more manageable, supporting consistent participation and data collection.

Scale across global studies

Standardized study components and localization capabilities help sponsors manage requirements across countries, languages, and sites.

Built to support mega trials

Large-scale clinical trials bring added complexity—from thousands of participants and high volumes of patient-reported data to global site coordination, device logistics, and demanding study timelines.Medable combines scalable eCOA technology, global delivery expertise, and device and logistics support to help sponsors manage large, complex trials while maintaining a consistent patient experience and reliable data collection

  • Scale with confidence. Support high participant volumes across multiple countries, languages, and sites.
  • Accelerate study deployment. Leverage Study Studio and reusable components to streamline study builds and support faster execution.
  • Simplify device and logistics management. Support provisioned-device needs, including device sourcing, provisioning, distribution, and ongoing logistics coordination across global study populations.
  • Keep patients engaged. Deliver intuitive, patient-centered assessments that support adherence across large, diverse populations.
  • Maintain consistent data collection. Standardize eCOA experiences across sites and regions while accommodating study-specific requirements.

Proven in Clinical Trials. Measured in Results.

XX

tbd

xx

Tbd

xx

Tbd

Case Studies

Case Studies

Proactive consent review helps pediatric studies stay ahead of FPI

A top-5 pharma partnered with Medable on two pediatric vaccine studies in South Africa, where parents and guardians consent on behalf of their children. By reviewing consent materials from the caregiver’s perspective, Medable flagged inconsistencies early enough for the sponsor to revise the forms and secure IRB re-approval before first patient in.

‍

Case Studies

Case study: Scaling global vaccine mega-trials for a top-5 pharma

Learn how Medable enabled a top-5 pharma to scale vaccine mega-trials with near-100% enrollment, real-time safety data, and >90% diary compliance.

‍

An older user consents to a clinical trial using eConsent
Case Studies

Case study: ICON and Medable drive 85% eConsent adoption in U.S. menopause study

How do you drive adoption in a complex women’s health study? See how ICON and Medable reached 85% eConsent uptake across 1,200+ participants with a smarter, site-first approach.